149 related articles for article (PubMed ID: 2998408)
1. Adenosine triphosphate pyrophosphohydrolase and neutral inorganic pyrophosphatase in pathologic joint fluids. Elevated pyrophosphohydrolase in calcium pyrophosphate dihydrate crystal deposition disease.
Rachow JW; Ryan LM
Arthritis Rheum; 1985 Nov; 28(11):1283-8. PubMed ID: 2998408
[TBL] [Abstract][Full Text] [Related]
2. Synovial fluid inorganic pyrophosphate concentration and nucleotide pyrophosphohydrolase activity in basic calcium phosphate deposition arthropathy and Milwaukee shoulder syndrome.
Rachow JW; Ryan LM; McCarty DJ; Halverson PC
Arthritis Rheum; 1988 Mar; 31(3):408-13. PubMed ID: 2833903
[TBL] [Abstract][Full Text] [Related]
3. Partial characterization of synovial fluid nucleotide pyrophosphohydrolase.
Rachow JW; Ryan LM
Arthritis Rheum; 1985 Dec; 28(12):1377-83. PubMed ID: 2935159
[TBL] [Abstract][Full Text] [Related]
4. Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate.
Ryan LM; Rachow JW; McCarty DJ
J Rheumatol; 1991 May; 18(5):716-20. PubMed ID: 1650841
[TBL] [Abstract][Full Text] [Related]
5. Inorganic pyrophosphate generation from adenosine triphosphate by cell-free human synovial fluid.
Park W; Masuda I; Cardenal-Escarcena A; Palmer DL; McCarty DJ
J Rheumatol; 1996 Apr; 23(4):665-71. PubMed ID: 8730124
[TBL] [Abstract][Full Text] [Related]
6. Elevated inorganic pyrophosphate concentrations in synovial fluids in osteoarthritis and pseudogout.
Silcox DC; McCarty DJ
J Lab Clin Med; 1974 Apr; 83(4):518-31. PubMed ID: 4361744
[No Abstract] [Full Text] [Related]
7. Synovial fluid 5'-nucleotidase activity. Relationship to other purine catabolic enzymes and to arthropathies associated with calcium crystal deposition.
Wortmann RL; Veum JA; Rachow JW
Arthritis Rheum; 1991 Aug; 34(8):1014-20. PubMed ID: 1650220
[TBL] [Abstract][Full Text] [Related]
8. Inorganic pyrophosphate, nucleoside triphosphate pyrophosphatase, and cartilage fragments in normal human synovial fluid.
Hamilton E; Pattrick M; Doherty M
Br J Rheumatol; 1991 Aug; 30(4):260-4. PubMed ID: 1650620
[TBL] [Abstract][Full Text] [Related]
9. Inorganic pyrophosphatase activity of the synovial fluid. Kinetic and clinical study.
Jacobelli S; Kettlun AM; Sapag-Hagar M
Arthritis Rheum; 1978 May; 21(4):447-52. PubMed ID: 26358
[TBL] [Abstract][Full Text] [Related]
10. Synovial fluid pyrophosphate and nucleoside triphosphate pyrophosphatase: comparison between normal and diseased and between inflamed and non-inflamed joints.
Pattrick M; Hamilton E; Hornby J; Doherty M
Ann Rheum Dis; 1991 Apr; 50(4):214-8. PubMed ID: 1851409
[TBL] [Abstract][Full Text] [Related]
11. Calcium pyrophosphate crystal deposition disease and other crystal deposition diseases.
Fam AG
Curr Opin Rheumatol; 1992 Aug; 4(4):574-82. PubMed ID: 1503884
[TBL] [Abstract][Full Text] [Related]
12. Nucleotide pyrophosphohydrolase in human synovial fluid.
Masuda I; Cardenal A; Ono W; Hamada J; Haas AL; McCarty DJ
J Rheumatol; 1997 Aug; 24(8):1588-94. PubMed ID: 9263156
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence Differentiation of ATP-related Multiple Enzymatic Activities in Synovial Fluid as a Marker of Calcium Pyrophosphate Deposition Disease using Kyoto Green.
Yongwattana N; Mekjinda N; Tawonsawatruk T; Hamachi I; Ojida A; Wongkongkatep J
Molecules; 2020 Mar; 25(5):. PubMed ID: 32131555
[TBL] [Abstract][Full Text] [Related]
14. Familial chondrocalcinosis due to calcium pyrophosphate dihydrate crystal deposition in English families.
Doherty M; Hamilton E; Henderson J; Misra H; Dixey J
Br J Rheumatol; 1991 Feb; 30(1):10-5. PubMed ID: 1846765
[TBL] [Abstract][Full Text] [Related]
15. Modulation of chondrocyte production of extracellular inorganic pyrophosphate.
Costello JC; Ryan LM
Curr Opin Rheumatol; 2004 May; 16(3):268-72. PubMed ID: 15103256
[TBL] [Abstract][Full Text] [Related]
16. [The solubility of calcium pyrophosphate dihydrate crystals].
Sakamoto H
Nihon Seikeigeka Gakkai Zasshi; 1995 Jul; 69(7):484-92. PubMed ID: 7561350
[TBL] [Abstract][Full Text] [Related]
17. Pyrophosphohydrolase activity and inorganic pyrophosphate content of cultured human skin fibroblasts. Elevated levels in some patients with calcium pyrophosphate dihydrate deposition disease.
Ryan LM; Wortmann RL; Karas B; Lynch MP; McCarty DJ
J Clin Invest; 1986 May; 77(5):1689-93. PubMed ID: 3009553
[TBL] [Abstract][Full Text] [Related]
18. NTP pyrophosphohydrolase in human chondrocalcinotic and osteoarthritic cartilage. I. Some biochemical characteristics.
Muniz O; Pelletier JP; Martel-Pelletier J; Morales S; Howell DS
Arthritis Rheum; 1984 Feb; 27(2):186-92. PubMed ID: 6141795
[TBL] [Abstract][Full Text] [Related]
19. Inorganic pyrophosphate pool size and turnover rate in arthritic joints.
Camerlain M; McCarty DJ; Silcox DC; Jung A
J Clin Invest; 1975 Jun; 55(6):1373-81. PubMed ID: 166095
[TBL] [Abstract][Full Text] [Related]
20. [Clinico-radiologic aspects of calcium pyrophosphate dihydrate deposition disease].
Orzincolo C; Castaldi G; Bariani L; Franceschini F; Lodi G; Bariani MC
Minerva Med; 1987 Mar; 78(5):281-6. PubMed ID: 3029632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
